First report of transperineal polyethylene glycol hydrogel spacer use to curtail rectal radiation dose after permanent iodine-125 prostate brachytherapy

被引:32
作者
Beydoun, Nadine [1 ]
Bucci, Joseph A. [1 ]
Chin, Yaw S. [1 ]
Malouf, David [2 ]
Enari, Ese [1 ]
Painter, Samuel D. [1 ]
机构
[1] St George Hosp, Dept Radiat Oncol, Kogarah, NSW 2217, Australia
[2] St George Hosp, Dept Urol, Kogarah, NSW 2217, Australia
关键词
Polyethylene glycol hydrogel; Seed brachytherapy; Spacing agent; Transperineal spacer; INTENSITY-MODULATED RADIOTHERAPY; CONFORMAL RADIOTHERAPY; ESCALATION TRIAL; TOXICITY; CANCER; GUIDELINES; MORBIDITY; THERAPY; RISK; GEL;
D O I
10.1016/j.brachy.2013.01.164
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: To demonstrate the feasibility of transperineal polyethylene glycol (PEG) hydrogel insertion into anterior perirectal fat for reducing rectal radiation dose in patients with suboptimal rectal dosimetry after permanent iodine-125 prostate brachytherapy. METHODS AND MATERIALS: Five patients with suboptimal rectal dosimetry after iodine-125 seed brachytherapy implant underwent a single transperineal injection of PEG hydrogel into the anterior perirectal fat under general anesthetic using transrectal ultrasound guidance. Prostate-rectum separation and rectal radiation dose before and after PEG hydrogel spacer insertion were measured. Toxicity because of spacer insertion was assessed at Days 0-1 and 4-6 weeks using National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0. RESULTS: All patients experienced a clinically significant reduction in the volume of rectum receiving greater than or equal to the prescription dose (RV100) on the postspacer postimplant dosimetry, compared with the prespacer postimplant dosimetry. Mean prostate rectum separation that was achieved with the insertion of the spacer was 15.1 mm (+/- 3.4). The mean difference in separation from before to after spacer insertion was 12.5 mm (+/- 4.5). This was associated with a reduction in mean RV100 from 3.04 (+/- 1.2) to 0.06 (+/- 0.1) cc. Toxicities were limited to Grade 1 (National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0) perineal pain and rectal discomfort (3/5 patients). There were no Grade 2 or greater toxicities reported after insertion of the spacer. CONCLUSIONS: PEG hydrogel is safe and effective at reducing rectal radiation dose in select patients with suboptimal rectal dosimetry after prostate seed brachytherapy. Crown Copyright (C) 2013 Published by Elsevier Inc. on behalf of American Brachytherapy Society. All rights reserved.
引用
收藏
页码:368 / 374
页数:7
相关论文
共 24 条
[1]   UPDATE OF DUTCH MULTICENTER DOSE-ESCALATION TRIAL OF RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER [J].
Al-Mamgani, Abrahim ;
van Putten, Wim L. J. ;
Heemsbergen, Wilma D. ;
van Leenders, Geert J. L. H. ;
Slot, Annerie ;
Dielwart, Michel F. H. ;
Incrocci, Luca ;
Lebesque, Joos V. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (04) :980-988
[2]   ROLE OF INTENSITY-MODULATED RADIOTHERAPY IN REDUCING TOXICITY IN DOSE ESCALATION FOR LOCALIZED PROSTATE CANCER [J].
Al-Mamgani, Abrahim ;
Heemsbergen, Wilma D. ;
Peeters, Stephanif T. H. ;
Lebesque, Joos V. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (03) :685-691
[3]   Brachytherapy for carcinoma of the prostate: Techniques, patient selection, and clinical outcomes [J].
Blasko, JC ;
Mate, T ;
Sylvester, JE ;
Grimm, PD ;
Cavanagh, W .
SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :81-94
[4]   American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy [J].
Davis, Brian J. ;
Horwitz, Eric M. ;
Lee, W. Robert ;
Crook, Juanita M. ;
Stock, Richard G. ;
Merrick, Gregory S. ;
Butler, Wayne M. ;
Grimm, Peter D. ;
Stone, Nelson N. ;
Potters, Louis ;
Zietman, Anthony L. ;
Zelefsky, Michael J. .
BRACHYTHERAPY, 2012, 11 (01) :6-19
[5]   Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial [J].
Dearnaley, David P. ;
Sydes, Matthew R. ;
Graham, John D. ;
Aird, Edwin G. ;
Bottomley, David ;
Cowan, Richard A. ;
Huddart, Robert A. ;
Jose, Chakiath C. ;
Matthews, John H. L. ;
Millar, Jeremy ;
Moore, A. Rollo ;
Morgan, Rachel C. ;
Russell, J. Martin ;
Scrase, Christopher D. ;
Stephens, Richard J. ;
Syndikus, Isabel ;
Parmar, Mahesh K. B. .
LANCET ONCOLOGY, 2007, 8 (06) :475-487
[6]  
HOWARD A, 2001, J BRACHYTHER INT, V17, P37
[7]   Late rectal toxicity: Dose-volume effects of conformal radiotherapy for prostate cancer [J].
Huang, EH ;
Pollack, A ;
Levy, L ;
Starkschall, G ;
Dong, L ;
Rosen, I ;
Kuban, DA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (05) :1314-1321
[8]   Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer [J].
Kuban, Deborah A. ;
Tucker, Susan L. ;
Dong, Lei ;
Starkschall, George ;
Huang, Eugene E. ;
Cheung, M. Rex ;
Lee, Andrew K. ;
Pollack, Alan .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (01) :67-74
[9]   Late rectal function after prostate brachytherapy [J].
Merrick, GS ;
Butler, WM ;
Wallner, KE ;
Hines, AL ;
Allen, Z .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (01) :42-48
[10]   Long-term urinary quality of life after permanent prostate brachytherapy [J].
Merrick, GS ;
Butler, WM ;
Wallner, KE ;
Galbreath, RW ;
Lief, JH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (02) :454-461